lianyungang, China

Lei Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical, Shanghai Shengdi Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lei Chen. Retrieved from https://idiyas.com/inventor/lei-chen-2a3e8e1j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lei Chen: Innovator in Biotechnology

Introduction

Lei Chen is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on human interleukin-2 variants. His research has the potential to impact various medical applications.

Latest Patents

Lei Chen holds a patent for a "Human Interleukin-2 Variant or Derivative Thereof." This patent showcases his expertise in developing biologically active molecules that can be utilized in therapeutic settings. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Throughout his career, Lei Chen has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Co., Ltd. and Shanghai Hengrui Pharmaceutical. His experience in these organizations has allowed him to collaborate with leading professionals in the field.

Collaborations

Lei Chen has worked alongside talented individuals such as Qiyue Hu and Hu Ge. These collaborations have enriched his research and contributed to the development of innovative solutions in biotechnology.

Conclusion

In summary, Lei Chen is a dedicated inventor whose work in biotechnology has led to valuable advancements. His patent on human interleukin-2 variants exemplifies his innovative spirit and commitment to improving medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…